Sort   by:  
 Page size 
ProteomicsANTIVENOMIC AND PROTEOMIC ASSESSMENT OF INTER- AND INTRA-POPULATION VENOM VARIATIONS IN NIKOLSKY'S ADDER VIPERA NIKOLSKII: COMPARISON TO COMMON ADDER VIPERA BERUS
This project provides an integrated proteomic and immunological dataset that documents inter‑ and intra‑population variation in venom composition for the forest‑steppe adder Vipera nikolskii and evaluates recognition by a commercial Vipera berus antivenom. The dataset includes label‑free LC–MS/MS ra...
ORGANISM(S): Vipera berus Vipera nikolskii 
2026-08-24 | PXD073454 | Pride
Venomics  proteomics  snake venom  vipera berus  vipera nikolskii  antivenom  variability 
UnknownPLA2 Inhibitor Varespladib as an Alternative to the Antivenom Treatment for Bites from Nikolsky's Viper Vipera berus nikolskii.
Not available
S-EPMC7354479 | biostudies-literature
UnknownEffects of the Heterodimeric Neurotoxic Phospholipase A2 from the Venom of Vipera nikolskii on the Contractility of Rat Papillary Muscles and Thoracic Aortas.
Not available
S-EPMC10891809 | biostudies-literature
UnknownQuantitative Proteomic Analysis of Venoms from Russian Vipers of Pelias Group: Phospholipases A₂ are the Main Venom Components.
Not available
S-EPMC4848631 | biostudies-literature
UnknownThe Procoagulant Snake Venom Serine Protease Potentially Having a Dual, Blood Coagulation Factor V and X-Activating Activity.
Not available
S-EPMC7354534 | biostudies-literature
UnknownSnake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2.
Not available
S-EPMC8554752 | biostudies-literature
UnknownInhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2.
Not available
S-EPMC4270787 | biostudies-literature
Sort   by:  
 Page size